Clinical Trial Update: Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study [Phase 4]

View source ↗

Summary

Phase 4 EST trial update comparing three antiplatelet drugs (clopidogrel, prasugrel, ticagrelor) in patients with coronary artery disease undergoing stenting. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BRILINTA (ticagrelor)
• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED